Details
Category: Volume 06 Issue 01 January 2018
Hits: 1200

Title: Carcinosarcoma of Uterus in a Younger Patient in a Tertiary Care Centre- A Case Report

Authors: Das Tripti, Das Kanti Tushar, Mukherjee Sanghamitra, Mahata Manisha, Barui Gopinath

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i1.107

Abstract

Carcinosarcoma is a rare malignant tumor of the uterus with poor prognosis. We, herein, present a case of uterine carcinosarcoma in a 32-year-old woman suffering from menorrhagia and vaginal bleeding for 6 months. It was clinically suspected as carcinoma of uterus. Total hysterectomy, bilateral salpingo-oophorectomy and pelvic lymph node dissection were done. The histological examination revealed that the tumor comprised components of poorly differentiated carcinoma and spinle cell sarcoma presumably fibrosarcoma accompanied by immature chondromatous element. Post-operative chemotherapy was given and patient was followed up closely.

Keywords: Carcinosarcoma, Malignant Mixed Mullerian Tumour, Sarcoma,Heterologous elements.

References

  1. Hubalek M, Ramoni A, Mueller-Holzner E, Marth C. Malignant mixed mesodermal tumor after tamoxifen therapy for breast cancer. Gynecol Oncol. 2004;95:264–266. [PubMed]
  2. Grigoriadis C, Androutsopoulos G, Zygouris D, Arnogiannaki N, Terzakis E. Uterine malignant mixed Mullerian tumor after adjuvant tamoxifen treatment for breast cancer. Eur J Gynaecol Oncol. 2013;34:94–98. [PubMed]
  3. Sebenik M, Yan Z, Khalbuss WE and Mittal Ket al: Malignant mixed mullerian tumor of the vagina: Case report with revi-ew of the literature, immunohisto-chemical study and evaluation for human papilloma virus. Hum Pathol 38: 1282-1288, 2007.
  4. sternberg’s Diagnostic Surgical Pathology, 6th edition,vol II ,2494
  5. Meyer, R.: in Veit-Stoeckel et al : 770-774, I930.
  6. S. Bosquet, S. A. Terstriep, W. A. Cliby et al: The impact of multi-modal therapy on survival for uterine carcinosarcomas, Gynecologic Oncology, vol. 116, no. 3, pp. 419–423, 2010.
  7. Ostor AG, Rollason TP (2003).Mixed tumours of the uterus. In:Haines &Taylor Obstetrical and Gynaecological Pathology. Fox H, Wells M,eds. Churchill Livingstone: 549-584.
  8. Emoto M., Iwasaki H., Kikuchi M., Ishiguro M.Kubota , Izumi H., Shirakawa K., Kaneko Y., Two cell lines established from mixed müllerian tumors of the uterus. Morphologic, immunocyto-chemical, and cytogenetic analyses, Cancer, 1992, 69(7):1759–1768
  9. Gorai I., Yanagibashi T., Taki A., Udagawa K., Miyagi E., NakazawaT., Hirahara F., Nagashima Y., Minaguchi H., Uterine carcinosarcoma is derived from a single stem cell: an in vitro study, Int J Cancer, 1997, 72(5):821–827.
  10. Amr S. S., Tavassolif. A., Hassan A. A., Issa A. A., Madanat F. F., Mixed mesodermal tumor of the uterus in a 4-year-old girl, 1986, Int J Gynecol Pathol, 5(4):371–378.
  11. Silverberg S. G.,Major F. J., Blessing J. A., Fetter B., Askin F. B., Liao S. Y., Miller A., Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases, Int J Gynecol Pathol, 1990, 9(1):1–19.
  12. Kanthan R, Senger JL Uterine carcinosarc-omas (malignant mixed müllerian tumours): a review with special emphasis on the controversies in management. Obstet Gynecol Int. 2011; 2011:470795.
  13. Ferguson SE, Tomos C, Hummer A, Barakat RR, Soslow RA(2007).Prognostic features of surgical stage I uterine carcino-sarcoma. Am J Surg Pathol 31:1653-1661.
  14. S. A. El-Nashar and A. Mariani, ―Uterine carcinosarcoma,‖ Clinical Obstetrics and  Gynecology, vol. 54, 2, pp. 292–304, 2011.

Corresponding Author

Das Tripti